Our founding team is fiercely committed to harnessing the power of cannabis to help patients.
- Our founder and our advising physician have already written 45,000+ cannabis medical documents
- We have direct-to-patient relationship opportunities with 30,000+ active medical patients and a current patient base of 7,000+ patients associated with Tidal’s own physicians
- We are mining 10+ years of actual patient use and clinical trial data and medically backed IP imported from Israel’s second-largest licensed cannabis producer
- We are proactively investing in R&D on novel derivative solutions for non-flower delivery products including beverages, topicals and medibles
- We are taking an active role in clinical research trials and have relationships in place with Canadian cannabis research institutes
